References
- Anantachaisilp S, Smith SM, Treetong A, Pratontep S, Puttipipatkhachorn S, Ruktanonchai UR. Chemical and structural investigation of lipid nanoparticles: Drug-lipid interaction and molecular distribution. Nanotechnology, 2010;21:1–11
- Attama AA, Muller-Goymann CC. Effect of beeswax modification on lipid matrix and solid lipid nanoparticle crystallinity. Colloids Surf A, 2008;315:189–95
- Braem C, Blaschke T, Panek-Minkin G, Schlupp P, Paepenmüller T, Müller-Goyman C, Mehnert W, Bittl W, Schäfer-Korting M, Kramer KD. Interaction of drug molecules with carrier systems as studied by parelectric spectroscopy and electron spin resonance. J Control Release, 2007;119:128–35
- Bunjes H, Koch M, Westesen K. Influence of emulsifier on the crystallization of solid lipid nanoparticles. Int J Pharm, 2003;92:1509–20
- Castelli F, Paglia C, Sarpietro MG, Rizza L, Bonina F. Characterization of indomethacin-loaded lipid nanoparticles by differential scanning calorimetry. Int J Pharm, 2005;304:231–8
- Chapman D. The polymorphism of glycerides. Chem Rev, 1962;62:433–56
- Choi KO, Aditya NP, Ko S. Effect of aqueous pH and electrolyte concentration on structure, stability and flow behavior of non-ionic surfactant based solid lipid nanoparticles. Food Chem, 2014;147:239–44
- Han F, Li S, Yin R, Liu H, Xu L. Effect of surfactants on the formation and characterization of a new type of colloidal drug delivery system: Nanostructured lipid carriers. Colloids Surf A, 2007;315:210–16
- Hanafy A, Spahn-Langguth H, Vergnauth P. Pharmacokinetic evaluation of oral fenofibrate nanosuspensions and SLN in comparison to conventional suspensions of micronized drug. Adv Drug Deliv Rev, 2007;59:419–26
- Hou DZ, Xie CS, Huang KJ, Zhu CH. The production and characteristics of solid lipid nanoparticles (SLNs). Biomaterials, 2003;24:1781–5
- Jenning V, Schäfer-Korting M, Gohla S. Vitamin A-loaded solid lipid nanoparticles for topical use: Drug release properties. J Control Release 2000b;66:115–26
- Jenning V, Thunemann AF, Gohla SH. Characterisation of a novel solid lipid nanoparticle carrier system based on binary mixtures of liquid and solid lipids. Int J Pharm, 2000a;199:167–77
- Jores K, Haberland A, Wartewig S, Mäder K, Mehnert W. Solid lipid nanoparticles (SLN) and oil-loaded SLN studied by spectrofluorometry and raman spectroscopy. Pharm Res, 2005;22:1887–97
- Jores K, Mehnert W, Drechsler M, Bunjes H, Johann C, Mäder K. Investigations on the structure of solid lipid nanoparticles (SLN) and oil-loaded solid lipid nanoparticles by photon correlation spectroscopy, field-flow fractionation and transmission electron microscopy. J Control Release, 2004;95:217–27
- Jores K, Mehnert W, Mäder K. Physicochemical investigations on solid lipid nanoparticles and on oil-loaded solid lipid nanoparticles: A nuclear magnetic resonance study. Pharm Res 2003;20:1274–83
- Lherm C, Müller RH, Puisieux F, Couvreur P. Alkylcyanoacrylate drug carriers: II. Cytotoxicity of cyanoacrylate nanoparticle with different alkyl chain length. Int J Pharm, 1992;84:13–22
- Li X, Nie S, Kong J, Li N, Ju C, Pan W. A controlled-release ocular delivery system for ibuprofen on nanostructured lipid carriers. Int J Pharm, 2008;363:177–82
- Liu D, Liu Z, Wang L, Zhang C, Zhang N. Nanostructured lipid carriers as novel carrier for parenteral delivery of docetaxel. Colloids Surf B, 2011;85:262–9
- Maiti K, Bhattacharya SC, Moulik SP, Panda AK. Physicochemistry of binary interacting mixtures of cetylpyridinium chloride (CPC) and sodium dodecylsulfate (SDS) with special reference to the catanionic ion-pair (coacervate) behavior. Colloids Surf A, 2010;355:88–98
- Mehnert W, Mäder K. Solid lipid nanoparticles: Production, characterization and applications. Adv Drug Deliv Rev, 2001;47:165–96
- Mulla Jameel Ahmed S, Shetty Nitinkumar S, Panchamukhi Shridhar I, Khazi Imtiyaz M. Formulation, characterization and in vitro evaluation of novel thienopyrimidines and triazolothienopyrimidines loaded solid lipid nanoparticles. IJRAP, 2010;1:192–200
- Müller RH, Radtke M, Wissing SA. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv Drug Deliv Rev, 2002a;54:131–55
- Müller RH, Radtke M, Wissing SA. Nanostructured lipid matrices for improved microencapsulation of drugs. Int J Pharm, 2002b;242:121–8
- Sajomsang W, Nuchuchua O, Gonil P, Saesoo S, Sramala I, Soottitantawat A, Puttipipatkhachorn S, Ruktanonchai UR. Water-soluble β-cyclodextrin grafted with chitosan and its inclusion complex as a mucoadhesive eugenol carrier. Carbohydr Polym, 2012;89:623–31
- Saupe A, Gordon KC, Rades T. Structural investigations on nanoemulsions, solid lipid nanoparticles and nanostructured lipid carriers by cryo-field emission scanning electron microscopy and Raman spectroscopy. Int J Pharm, 2006;314:56–62
- Schlichter AJ, Sarig S, Garti N. Dynamic control of polymorphic transformation in triglycerides by surfactant: The button syndrome. J Am Oil Chem Soc, 1988;65:1144–50
- Schöler N, Olbrich C, Tabbatt K, Müller RH, Hahn H, Liesenfeld O. Surfactant, but not the size of solid lipid nanoparticles (SLN) influences viability and cytokine production of macrophages. Int J Pharm, 2001;221:57–67
- Sivaramakrishnan R, Nakamura C, Mehnert W, Korting HC, Kramer KD, Schäfer-Korting M. Glucocorticoid entrapment into lipid carrier-characterization by parelectric spectroscopy and influence on dermal uptake. J Control Release, 2004;97:493–502
- Souto EB, Müller RH. Lipid nanoparticles: Effect on bioavailability and pharmacokinetic changes. Drug Deliv, 2010;197:115–41
- Tan SW, Billa N, Roberts CR, Burley JC. Surfactant effects on the physical characteristics of Amphotericin B-containing nanostructured lipid carriers. Colloids Surf A 2010;372:73–9
- Teeranachaideekul V, Boonme P, Souto EB, Müller RH, Junyaprasert VB. Influence of oil content on physicochemical properties and skin distribution of Nile red-loaded NLC. J Control Release 2008;128:134–41
- Teeranachaideekul V, Souto EB, Junyaprasert VB, Müller RH. Cetylpalmitate based NLC for topical delivery of coenzyme Q10-development, physicochemical characterization and in vitro release studies. Eur J Pharm Biopharm 2007;67:141–8
- Wissing SA, Kayser O, Müller RH. Solid lipid nanoparticles for parenteral drug delivery. Adv Drug Deliv Rev, 2004;56:1257–72
- Yuan H, Wang LL, Du YZ, Hu FQ, Zeng S. Preparation and characteristics of nanostructured lipid carriers for control-releasing progesterone by melt emulsification. Colloids Surf B, 2007;60:174–9
- Zadeh B, Barati N, Hassani M, Rahim F. Development of solid lipid nanoparticles as Eschar delivery system for Nitrofurazone using Taguchi design approach. Int J Res Pharm Sci, 2010;1:466–72
- Zhang J, Xu G, Zhou Y, Zhou T, Zhai X. Polyhedral vesicles with crystalline bilayers formed from cationic surfactant mixtures of fluorocarbon and hydrocarbon amphiphiles. J Colloid Interface Sci, 2013;407:318–26